Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea · Delayed Price · Currency is KRW 26,350
0.00 (0.00%)
Jun 4, 2026, 1:34 PM KST
Daihan Pharmaceutical Revenue
Daihan Pharmaceutical had revenue of 52.71B KRW in the quarter ending March 31, 2026, with 5.66% growth. This brings the company's revenue in the last twelve months to 211.44B, up 3.11% year-over-year. In the year 2025, Daihan Pharmaceutical had annual revenue of 208.61B with 2.16% growth.
Revenue (ttm)
211.44B
Revenue Growth
+3.11%
P/S Ratio
0.73
Revenue / Employee
382.35M
Employees
553
Market Cap
154.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 208.61B | 4.42B | 2.16% |
| Dec 31, 2024 | 204.19B | 8.28B | 4.23% |
| Dec 31, 2023 | 195.91B | 11.64B | 6.32% |
| Dec 31, 2022 | 184.27B | 12.80B | 7.47% |
| Dec 31, 2021 | 171.46B | 5.38B | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewon Pharmaceutical | 605.66B |
| Jeil Pharmaceutical Co.,Ltd | 534.52B |
| Dongwha Pharm.Co.,Ltd | 501.33B |
| Ilyang Pharmaceutical Co.,Ltd | 275.51B |
| JW Lifescience | 252.72B |
| HLB Pharmaceutical | 236.59B |
| Samil Pharmaceutical Co.,Ltd | 210.51B |
| Hana Pharm | 139.33B |